Instrument Inactif

Gouvernance Aastrom Biosciences Inc Nasdaq

US00253U3059

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

31/07	Vericel Corporation : Truist Securities optimiste sur le dossier	ZM
30/07	Vericel Corporation autorise un plan de rachat d'actions.	CI

Comité Exécutif: Aastrom Biosciences Inc

Dirigeant

Fonctions occupéesDepuis

Dominick Colangelo

62 ans

Chief Executive Officer	01/03/2013
President	01/03/2013

Mike Gilligan

Sales & Marketing

01/01/2022

Karen Mahoney

82 ans

Human Resources Officer

22/07/2024

Patrick Helfrich

Sales & Marketing

01/01/2023

Eric Burns

Investor Relations Contact

Jonathan Siegal

47 ans

Comptroller/Controller/Auditor

Joseph Mara

51 ans

Director of Finance/CFO

25/01/2021

Sean Flynn

52 ans

General Counsel

06/11/2019

Jonathan Hopper

63 ans

Chief Tech/Sci/R&D Officer

20/08/2018

Roland DeAngelis

Sales & Marketing

Michael Halpin

64 ans

Chief Operating Officer

15/06/2019

Meredith Frank Molnia

Chief Tech/Sci/R&D Officer

01/01/2024

Composition du Conseil d'Administration: Aastrom Biosciences Inc

Administrateur

ComitésDepuis

Robert Zerbe

75 ans

Audit Committee	01/05/2016
Governance Committee	01/05/2016
Nominating Committee	01/05/2016

Heidi Hagen

57 ans

Compensation Committee	09/03/2015
Governance Committee Chair
Nominating Committee Chair	23/08/2013
Governance Committee	03/08/2026
Nominating Committee	03/08/2026
Compensation Committee Chair	03/08/2026

Paul Wotton

65 ans

Compensation Committee	01/03/2025
Governance Committee	06/01/2015
Nominating Committee	06/01/2015

Kevin McLaughlin

69 ans

Audit Committee Chair	21/05/2024
Nominating Committee	11/06/2018
Compensation Committee Chair

Dominick Colangelo

62 ans

Audit Committee	29/06/2020
Compensation Committee	01/09/2020

Lisa Wright

51 ans

Governance Committee	02/06/2021
Nominating Committee	01/06/2021

Alan Rubino

71 ans

Audit Committee	16/09/2010
Compensation Committee Chair	28/10/2009

Anciens Dirigeants et Administrateurs: Aastrom Biosciences Inc

Insider

Fonctions occupées

DepuisJusqu'au

Steven Gilman

Director/Board Member	06/01/2015	30/04/2025
Independent Dir/Board Member	06/01/2015	30/04/2025

Julie Downs

Public Communications Contact

01/04/2022

01/01/2025

Heidi Hassen

Human Resources Officer

01/09/2010

22/07/2024

Sandra Pennell

Comptroller/Controller/Auditor

01/09/2020

02/07/2021

Gerard Michel

Comptroller/Controller/Auditor	02/06/2014	-
Director of Finance/CFO	02/06/2014	30/09/2020

Daniel R. Orlando

Chief Operating Officer

01/08/2012

14/06/2019

Ross Tubo

Chief Tech/Sci/R&D Officer

01/04/2014

01/01/2017

Nelson M. Sims

Director/Board Member	15/12/2009	12/05/2015
Chairman	28/10/2009	15/12/2009
Independent Dir/Board Member	28/10/2011	12/05/2015

Jacquelyn Sandell

General Counsel

01/01/2015

Ronald M. Cresswell

Director/Board Member	26/10/2010	07/05/2014
Independent Dir/Board Member	31/10/2011	07/05/2014

David Recker

Chief Tech/Sci/R&D Officer

01/04/2014

Ronnda L. Bartel

Chief Tech/Sci/R&D Officer

01/10/2006

31/12/2013

Brian D. Gibson

Comptroller/Controller/Auditor	14/10/2011	31/08/2013
Corporate Secretary	01/07/2010	31/08/2013
Treasurer	14/10/2011	31/08/2013

Tim Mayleben

Director/Board Member	01/06/2005	02/05/2013
Chief Executive Officer	01/06/2005	02/05/2013
Director of Finance/CFO	15/12/2009	09/06/2010
President	15/12/2009	13/12/2012

Harold C. Urschel

Director/Board Member	21/10/2009	26/11/2012
Independent Dir/Board Member	31/10/2011	26/11/2012

Michael W. Elliston

Comptroller/Controller/Auditor	01/12/2011	07/05/2014
Director of Finance/CFO	01/12/2011	-
Corporate Secretary	01/12/2011	-
Treasurer	01/12/2011	07/05/2014

Scott Durbin

Director of Finance/CFO	09/06/2010	13/10/2011
Corporate Secretary	14/09/2010	13/10/2011
Treasurer	09/06/2010	13/10/2011

George Dunbar

Director of Finance/CFO	17/07/2006	21/10/2010
President	17/07/2006	21/10/2010

Elmar R. Burchardt

Chief Tech/Sci/R&D Officer

01/07/2006

30/05/2010

Sharon M. Watling

Chief Tech/Sci/R&D Officer	25/06/2012	-
Corporate Officer/Principal	24/05/2010	25/06/2012

Stephen G. Sudovar

Director/Board Member

01/07/2005

03/10/2009

Gerald D. Brennan

Chief Administrative Officer	01/02/2009	01/02/2009
Chief Operating Officer	01/02/2009	01/02/2009
Director of Finance/CFO	01/02/2009	01/02/2009

Peter C. Alain

Corporate Officer/Principal

01/08/2007

Sheldon A. Schaffer

Corporate Officer/Principal

01/12/2006

R. Armstrong

Chief Executive Officer	01/01/1987	01/01/1991
Chairman	01/01/1987	22/11/2006
President	01/01/1987	01/01/1991

James Andrew Cour

Chief Operating Officer	01/07/2004	14/07/2006
President	01/07/2004	14/07/2006

Tod Borton

Chief Tech/Sci/R&D Officer	28/10/2009	28/10/2009
Corporate Officer/Principal	28/10/2009	-

Sherrill M. MacKay

Corporate Officer/Principal

28/10/2009

Frances J. Kivel

Corporate Officer/Principal

28/10/2009

Linda Manoogian Fingerle

Director/Board Member

01/02/2004

28/09/2005

Joseph A. Taylor

Director/Board Member

01/11/1998

02/09/2005

Arthur F. Staubitz

Director/Board Member

01/03/1999

19/08/2005

Warren Bogard

Director/Board Member

10/05/2005

Martin C. Peters

Sales & Marketing

01/01/2005

Alan M. Wright

Chief Administrative Officer	01/01/2002	01/01/2005
Director of Finance/CFO	01/01/2002	01/01/2005

Janet Mary Hock

Chief Tech/Sci/R&D Officer

01/09/2004

Francisco Vidal

Corporate Officer/Principal

28/10/2009

Robert J. Bard

General Counsel

01/10/2002

Susan L. Wyant

Director/Board Member

01/06/2002

Todd Simpson

Chief Administrative Officer	01/01/1996	01/10/2001
Director of Finance/CFO	01/01/1996	01/10/2001
Chief Administrative Officer	01/01/1992	02/01/1995
Director of Finance/CFO	01/01/1992	02/01/1995

Kris M. Maly

Chief Administrative Officer	28/10/2009	-
Public Communications Contact	01/01/2000	-

Ramkumar Mandalam

Chief Tech/Sci/R&D Officer	01/01/1994	01/01/2000
Corporate Officer/Principal	01/01/1994	01/01/2000

Alan K. Smith

Chief Tech/Sci/R&D Officer

01/01/1995

01/01/2000

Walter Ogier

Sales & Marketing

01/01/1994

02/01/1997

Julie A. Caudill

Comptroller/Controller/Auditor	28/10/2009	-
Corporate Secretary	01/01/1995	-

Brian S. Hampson

Corporate Officer/Principal

01/07/1993

Bernhard Palsson

Founder	04/01/2011	-
Corporate Officer/Principal	01/01/1988	-

Donna Oppelt

Human Resources Officer	16/09/2010	-
Public Communications Contact	01/07/2009	16/09/2010

Kimberli O'Meara

Investor Relations Contact	31/10/2011	-
Public Communications Contact	-	-

Mary L. Campbell

Director/Board Member

LaVonne Lang

General Counsel

Bradley J. Martin

Corporate Officer/Principal

Douglas M. Smith

Corporate Officer/Principal

Manfred R. Koller

Corporate Officer/Principal

David Hoffman

Compliance Officer

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	15
Femme	5

Dont comité exécutif

Homme	10
Femme	2

Dont Administrateurs

Homme	5
Femme	2

Vericel Corporation est un fournisseur de thérapies de pointe destinées aux marchés de la médecine sportive et du traitement des brûlures graves. La société dispose d’un portefeuille différencié de produits de thérapie cellulaire et de produits biologiques spécialisés. Elle commercialise trois produits aux États-Unis. Le MACI (chondrocytes autologues cultivés sur une membrane de collagène porcin) est un produit de support cellulaire autologue indiqué pour la réparation des lésions cartilagineuses symptomatiques, simples ou multiples, de pleine épaisseur du genou, avec ou sans atteinte osseuse, chez l’adulte. Epicel (autogreffes épidermiques cultivées) est un substitut cutané permanent destiné au traitement des patients présentant des brûlures dermiques profondes ou de pleine épaisseur couvrant au moins 30 % de la surface corporelle totale. La Société détient également une licence pour les droits nord-américains de NexoBrid (anacaulase-bcdb), un produit biologique orphelin contenant des enzymes protéolytiques, indiqué pour l'exérèse des escarres chez les adultes et les enfants présentant des brûlures thermiques profondes de deuxième et/ou de troisième degré.

Employés

Secteur

Produits pharmaceutiques

Plus d'informations sur la société